Red Light Holland Looking Forward to AGSM, Including Corporate Update from Chairman Brad J Lamb and a Live Q&A With CEO Todd Shapiro on March 23rd at 11 AM
Brad J Lamb, Red Light Holland’s Chairman of the Board will Chair the AGSM, which takes place at 11 am EST on March 23, 2023CEO Todd Shapiro, CTIO Sarah…
Brad J Lamb, Red Light Holland’s Chairman of the Board will Chair the AGSM, which takes place at 11 am EST on March 23, 2023
CEO Todd Shapiro, CTIO Sarah Hashkes and CFO David Ascott of Red Light Holland will conduct a live Q&A immediately after the AGSM
The AGSM will take place in person at the offices of the Company located at 1 Adelaide Street East, Suite 801, Toronto, Ontario, M5C 2V9
The AGSM can be viewed via a Zoom broadcast at https://us06web.zoom.us/j/83661665783?pwd=YmgzcVh1VlF0emQ1UlZQZUNWRW9aZz09
Toronto, Ontario–(Newsfile Corp. – March 21, 2023) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland” or the “Company“), a company engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal, recreational market within the Netherlands, in compliance with all applicable laws, is excited to have Registered Shareholders, as of February 6, 2023, attend the Company’s Annual General and Special Meeting of Shareholders on Thursday, March 23, 2023 at 11 am (“AGSM“).
Red Light Holland requests that for those Registered Shareholders who intend to attend the AGSM, to please RSVP with Maggie at maggie@RedLight.co ASAP. Thank you in advance for your communication to help us prepare for those attending in person.
As well, for shareholders who cannot attend in person, the AGSM will be broadcast via Zoom at https://us06web.zoom.us/j/83661665783?pwd=YmgzcVh1VlF0emQ1UlZQZUNWRW9aZz09.
Red Light Holland would like to remind shareholders that Brad J Lamb, Chairman of the Board of Directors, will Chair this week’s AGSM and CEO and Director Todd Shapiro, CTIO Sarah Hashkes and CFO David Ascott are providing a live Q&A session immediately after the AGSM.
Once again, Red Light Holland’s AGSM is on Thursday, March 23rd at 11 am followed by a live Q&A – available online via zoom:
Meeting ID: 836 6166 5783
One tap mobile
Dial by your location
+1 305 224 1968 US
+1 309 205 3325 US
+1 312 626 6799 US (Chicago)
+1 346 248 7799 US (Houston)
+1 360 209 5623 US
+1 386 347 5053 US
+1 507 473 4847 US
+1 564 217 2000 US
+1 646 558 8656 US (New York)
+1 646 931 3860 US
+1 669 444 9171 US
+1 689 278 1000 US
+1 719 359 4580 US
+1 720 707 2699 US (Denver)
+1 253 205 0468 US
+1 253 215 8782 US (Tacoma)
+1 301 715 8592 US (Washington DC)
Meeting ID: 836 6166 5783
Find your local number: https://us06web.zoom.us/u/kblSvryWIk
About Red Light Holland
Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal, recreational market within the Netherlands, in compliance with all applicable laws.
For additional information on the Company:
Chief Executive Officer & Director
Tel: 647-643-TRIP (8747)
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events.
The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements regarding: the date, time and location of the AGSM, Q&A session, and the AGSM being broadcast via Zoom and Mr. Lamb chairing the AGSM and providing a corporate update.
Forward-looking information in this press release is based on certain assumptions and expected future events, namely: the date, time and location of the AGSM and Q&A session will be as outlined herein; the AGSM will be broadcast via zoom; and Mr. Lamb will chair the AGSM and provide a corporate update.
These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: risks that the date, time and location of the AGSM and Q&A session will not be as outlined herein; the Company will not broadcast the AGSM and Q&A via Zoom and that Mr. Lamb will be unable to chair the AGSM and/or not provide a corporate update.
Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.
Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/159228
canadian securities exchange
red light holland corp
Autolus to hold Annual General Meeting (AGM) of Shareholders on Friday, June 30, 2023
LONDON, June 06, 2023 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation…
Algernon Pharmaceuticals to Present Phase 2 Ifenprodil Cough Data at the 2023 American Cough Conference
VANCOUVER, British Columbia, June 06, 2023 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company”…
XORTX Announces PKD Presentation
XORTX ADPKD Data Presented at PKD Foundation MeetingCALGARY, Alberta, June 06, 2023 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. ("XORTX" or the “Company”)…
Digital Health20 hours ago
Best Penny Stocks To Buy Now? 4 Under $5 To Watch This Week
Digital Health14 hours ago
Air Force Colonel Caught Lying about Rogue AI Killing Human Operator
Government14 hours ago
Renowned sociologist and Black Voices Quintet set to dazzle at HDR UK’s Black Internship Programme Opening Ceremony 2023
Digital Health11 hours ago
AgreeYa Solutions Named Best Place to Work by CEO Insights
Life Sciences21 hours ago
Cancer discoveries could enhance immunotherapy, breast cancer care
Life Sciences17 hours ago
How CAR T Therapy Reimagines Cancer Treatment and More
Medtech23 hours ago
Leopard tanks ‘seen in battle for first time’
Life Sciences23 hours ago
Lunit and Capio S:t Göran Hospital Collaborate to Address Radiologist Shortage with AI-Powered Mammography Analysis